Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 5—May 2023
Letter

Nomenclature for Human Infections Caused by Relapsing Fever Borrelia

Cite This Article

To the Editor: Vazquez et al. report a convincing case of relapsing fever caused by Borrelia lonestari bacteria (1). This discovery highlights an existing problem with the nomenclature for relapsing fever.

Tick-borne relapsing fever (TBRF) is the name given to illness caused by several genospecies of relapsing fever Borrelia bacteria, all of which are transmitted by argasid (soft) ticks (2). The limitations of this term became apparent after discovery of B. miyamotoi, a related genospecies that is transmitted by ixodid (hard) ticks and causes illness that differs epidemiologically from traditional TBRF (3). Consequently, 3 terms are used in the scientific literature to describe B. miyamotoi infections: Borrelia miyamotoi disease, hard tick–borne relapsing fever, and hard tick relapsing fever (3,4). In the interest of standard nomenclature, it is worth considering objectively the relative merits of each term.

The term Borrelia miyamotoi disease (BMD) is problematic because it is species specific and cannot accommodate the discovery of related pathogens transmitted by ixodid ticks, including potentially B. lonestari (1,3). Disease names are most serviceable as umbrella terms that exist above the species level (e.g., Lyme disease, shigellosis).

The term hard tick–borne relapsing fever has a different problem, a grammatical one. The word hard rightly modifies tick, not tick-borne, which is a mode of transmission. This problem is solved by shortening to hard tick relapsing fever. The suffix “-borne” is not essential for clarity, as demonstrated by other established names (e.g., sand fly fever, Colorado tick fever) (2).

In the absence of a formal nomenclature decision by the World Health Organization, the following terms are consistent with precedent, epidemiologically useful, linguistically sensible replacements for TBRF: hard tick relapsing fever (HTRF) for illness caused by relapsing fever–clade Borrelia transmitted by ixodid ticks, and its congener, soft tick relapsing fever (STRF), for related agents transmitted by argasid ticks.

Top

Paul S. MeadComments to Author 
Author affiliation: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA

Top

References

  1. Vazquez Guillamet  LJ, Marx  GE, Benjamin  W, Pappas  P, Lieberman  NAP, Bachiashvili  K, et al. Relapsing fever caused by Borrelia lonestari after tick bite in Alabama, USA. Emerg Infect Dis. 2023;29:4414. DOIPubMedGoogle Scholar
  2. World Health Organization. International Classification of Diseases, 11th revision. 2022 [cited Jan 31]. https://icd.who.int
  3. Telford  SR III, Molloy  PJ, Berardi  VP. Borrelia miyamotoi. Ann Intern Med. 2015;163:9634. DOIPubMedGoogle Scholar
  4. Rodino  KG, Pritt  BS. When to think about other Borrelia: hard tick relapsing fever (Borrelia miyamotoi), Borrelia mayonii, and beyond. Infect Dis Clin North Am. 2022;36:689701. DOIPubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid2905.230195

Original Publication Date: April 14, 2023

Related Links

Top

Table of Contents – Volume 29, Number 5—May 2023

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Paul S. Mead, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO 80521, USA

Send To

10000 character(s) remaining.

Top

Page created: April 04, 2023
Page updated: April 19, 2023
Page reviewed: April 19, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external